Model Number 3CX*NX19RE |
Device Problem
Leak/Splash (1354)
|
Patient Problems
Death (1802); Heart Failure (2206)
|
Event Date 01/29/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
Terumo has received the device for evaluation; however, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.(b)(4).
|
|
Event Description
|
The user facility reported to terumo cardiovascular that during cardiopulmonary bypass, the oxygenator was foaming.Per user facility, the case was an aortic aneurysm dissection and they were on bypass for 3.5 hours then another 1 to 1.5 hours off again and then on for 15-20 minutes.The oxygenator was foaming and the end of the case, p02 dropped, they transferred to extracorporeal membrane oxygenation (ecmo), which was necessary due to the patient's right heart failure.The patient expired at a later date.There was slight blood colored plasma at the end.The product was not changed out but they did add a fx15 oxygenator into the circuit to have as a backup, (it was not used).The surgery was completed successfully.
|
|
Manufacturer Narrative
|
This follow-up report is submitted to fda in accord with applicable regulations and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on february 18, 2020.Upon further investigation of the reported event, the following information is new and/or changed: d4: (additional device information: added expiration date).G4: (date received by manufacturer).G7: (indication that this is a follow-up report).H2: (follow-up due to additional information and device evaluation).H3: (device evaluated by manufacturer).H4: (device manufacture date).H6: (identification of evaluation codes 10, 3331, 4210, 4315).Method code #1: 10 - testing of actual/suspected device.Method code #2: 3331 - analysis of production records.Results code: 4210 - leakage/seal.Conclusions code: 4315 - cause not established.The affected sample was returned and visually inspected upon receipt with no anomalies noted.Sem analysis and review of perfusion records has been conducted and has been unsuccessful in determining the cause of this event.The unit was dissected and dyed with nile blue a.This is a water-soluble dye that has the ability to stain neutral fats and phospholipids in different colors.This analysis showed that no red blood cells were remaining in the unit, and that the substances are derived from plasma.An engineering investigation has been initiated to determine a root cause.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
|
Search Alerts/Recalls
|
|